B-type natriuretic peptide and prognosis of end-stage renal disease: A meta-analysis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Cheng, Yun Jiu ^a   Yao, Feng Juan ^a   Liu, Li Juan ^a   Tang, Kai ^a   Lin, Xiao Xiong ^a   Li, Wei Jie ^a   Zhang, Jing ^a   Wu, Su Hua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DATA PROCESSING; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; HUMAN; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; PUBLISHING; RISK ASSESSMENT; SYSTEMATIC REVIEW; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; FEMALE; MALE; META ANALYSIS; METABOLISM; RISK;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PROGNOSIS;

EID: 84893344712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079302     Document Type: Article

References (53)

1. Herzog CA, Ma JZ, Collins AJ (1998) Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339: 799-805.
2. Daniels LB, Maisel AS (2007) Natriuretic peptides. J Am Coll Cardiol 50: 2357-2368.
3. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
4. Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, et al. (2007) Nterminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 71: 548-554.
5. Satyan S, Light RP, Agarwal R (2007) Relationships of N-terminal pro-Bnatriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 50: 1009-1019.
6. Wang AY, Lam CW, Yu CM, Wang M, Chan IH, et al. (2007) N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol 18: 321-330.
7. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, et al. (2001) Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12: 1508-1515.
8. Dastoor H, Bernieh B, Boobes Y, Abouchacra S, Eltayeb E, et al. (2005) Plasma BNP in patients on maintenance haemodialysis: a guide to management? J Hypertens 23: 23-28.
9. Mark PB, Petrie CJ, Jardine AG (2007) Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure. Semin Dial 20: 40-49.
10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
11. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25.
12. Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, et al. (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2: 9.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
14. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
15. Koch M, Trapp R, Kohnle M, Aker S, Haastert B, et al. (2010) B-type natriuretic peptide and severe heart failure at baseline predict overall mortality in incident dialysis patients. Clin Nephrol 73: 21-29.
16. Codognotto M, Piccoli A, Zaninotto M, Mion MM, Ruzza L, et al. (2010) Effect of a dialysis session on the prognostic values of NT-proBNP, troponins, endothelial damage and inflammation biomarkers. J Nephrol 23: 465-471.
17. Hallen J, Madsen L, Ladefoged S, Fagerland MW, Serebruany VL, et al. (2011) Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease. Scand J Urol Nephrol 45: 151-158.
18. Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH (2009) NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease. Clin Nephrol 71: 380-386.
19. Trape J, Perez A, Naval I, Escudero J, Comerma I, et al. (2008) Nt-proBNP in haemodialysis patients: a preliminary study. Scand J Clin Lab Invest 68: 415-420.
20. Guo Q, Barany P, Qureshi AR, Snaedal S, Heimburger O, et al. (2009) N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients. Am J Nephrol 29: 516-523.
21. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, et al. (2006) Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart 92: 1518-1519.
22. Biasioli S, Zamperetti M, Borin D, Guidi G, De Fanti E, et al. (2007) Significance of plasma B-type natriuretic peptide in hemodialysis patients: blood sample timing and comorbidity burden. ASAIO J 53: 587-591.
23. Sivalingam M, Suresh M, Farrington K (2011) Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration. Hemodial Int 15: 359-365.
24. Selim G, Stojceva-Taneva O, Spasovski G, Georgievska-Ismail L, Zafirovska-Ivanovska B, et al. (2011) Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up. Nephron Clin Pract 119: c162-c170.
25. Westenbrink BD, Hovinga TK, Kloppenburg WD, Veeger NJ, Janssen WM (2011) B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patients. Clin Nephrol 76: 373-379.
26. Apple FS, Murakami MM, Pearce LA, Herzog CA (2004) Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for allcause death. Clin Chem 50: 2279-2285.
27. Paniagua R, Ventura MD, Avila-Diaz M, Hinojosa-Heredia H, Mendez-Duran A, et al. (2010) NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 25: 551-557.
28. Gutierrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, et al. (2008) N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clin Chem 54: 1339-1348.
29. Paniagua R, Amato D, Mujais S, Vonesh E, Ramos A, et al. (2008) Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial. Clin J Am Soc Nephrol 3: 407-415.
30. Foley RN, Curtis BM, Randell EW, Parfrey PS (2010) Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 5: 805-813.
31. Roberts MA, Srivastava PM, Macmillan N, Hare DL, Ratnaike S, et al. (2008) B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis. Clin J Am Soc Nephrol 3: 1057-1065.
32. Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, et al. (2009) Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J 39: 812-818.
33. Kim YK, Shin SJ, Ihm SH, Park CS, Kim HY, et al. (2010) Association between N-terminal pro-brain natriuretic peptide and acute ischemic stroke in patients on chronic hemodialysis. Int Urol Nephrol 42: 537-543.
34. Goto T, Takase H, Toriyama T, Sugiura T, Kurita Y, et al. (2002) Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 92: 610-615.
35. Sun L, Sun Y, Zhao X, Xu C, Chen D, et al. (2008) Predictive role of BNP and NT-proBNP in hemodialysis patients. Nephron Clin Pract 110: c178-c184.
36. Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, et al. (2001) Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clin Chim Acta 312: 69-79.
37. Naganuma T, Sugimura K, Wada S, Yasumoto R, Sugimura T, et al. (2002) The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22: 437-444.
38. Herselman M, Esau N, Kruger JM, Labadarios D, Moosa MR (2010) Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. Nutrition 26: 10-32.
39. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A (2005) Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 112: 3088-3096.
40. Heinz J, Kropf S, Luley C, Dierkes J (2009) Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Am J Kidney Dis 54: 478-489.
41. Safley DM, Awad A, Sullivan RA, Sandberg KR, Mourad I, et al. (2005) Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv Chronic Kidney Dis 12: 117-124.
42. Dastoor H, Bernieh B, Boobes Y, Abouchacra S, Eltayeb E, et al. (2005) Plasma BNP in patients on maintenance haemodialysis: a guide to management? J Hypertens 23: 23-28.
43. Flemmer M, Rajab H, Mathena T, Paulson J, Perkins S, et al. (2008) Blood B-type natriuretic peptide and dialysis: present assessment and future analyses. South Med J 101: 1094-1100.
44. Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, et al. (2001) Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am J Kidney Dis 37: 1201-1208.
45. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ (2003) Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 41: 1257-1266.
46. Booth J, Pinney J, Davenport A (2010) N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 5: 1036-1040.
47. Ritz E (2011) Intestinal-renal syndrome: mirage or reality? Blood Purif 31: 70-76.
48. Paniagua R, Ventura MD, Avila-Diaz M, Hinojosa-Heredia H, Mendez-Duran A, et al. (2010) NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 25: 551-557.
49. de Lemos JA, McGuire DK, Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362: 316-322.
50. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, et al. (2005) Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46: 118-123.
51. Palmer SC, Richards AM (2009) Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)? J Am Coll Cardiol 53: 891-892.
52. van Kimmenade RR, Januzzi JJ, Bakker JA, Houben AJ, Rennenberg R, et al. (2009) Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol 53: 884-890.
53. Schou M, Alehagen U, Goetze JP, Gustafsson F, Dahlstrom U (2009) Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals. Heart 95: 1514-1519.